Iris Medicine
- Biotech or pharma, therapeutic R&D
Iris Medicine is advancing a new RNA modality, small binding RNA (sbRNA), to achieve allele-selective inhibition for the repeat expansion diseases.
June 16-19, 2025
Boston Convention & Exhibition Center
Iris Medicine is advancing a new RNA modality, small binding RNA (sbRNA), to achieve allele-selective inhibition for the repeat expansion diseases.